Antibiotics for Diabetes with Bone Fractures

This trial aims to determine if taking an antibiotic pill (Cefadroxil) for 7 days after surgery can reduce the risk of wound infections in adults with poorly controlled diabetes who have undergone surgery to repair a broken leg, ankle, or foot. Researchers will compare this 7-day antibiotic course to the usual care, which involves no additional antibiotics after surgery. They will also assess the safety of these antibiotics for participants. Candidates may qualify if they have had a lower body fracture requiring surgery and have poorly controlled diabetes. As a Phase 4 trial, this research focuses on understanding how the already FDA-approved and effective treatment can benefit more patients with similar conditions.

The trial information does not specify if you need to stop taking your current medications. However, if you have a current infection requiring antibiotics or are on immunosuppressant medications, you may not be eligible to participate.

Research has shown that cefadroxil, the antibiotic used in this trial, is generally safe for people. In studies involving long-term antibiotic use, such as those for hip or knee surgeries, most participants tolerated the antibiotics well. Serious side effects were rare, though some individuals experienced mild stomach upset or diarrhea, which is common with antibiotics.

This trial is in a later phase, indicating that cefadroxil has already undergone significant safety testing. By this stage, any serious side effects would likely be known. Additionally, cefadroxil has FDA approval for other uses, further supporting its safety.

Researchers are excited about using cefadroxil for diabetes patients with bone fractures because it offers an extended oral antibiotic prophylaxis that goes beyond the typical perioperative protocols. While standard care usually involves short-term antibiotics to prevent infection during surgery, cefadroxil provides continued protection, potentially reducing the risk of post-operative infections. This extended approach could be particularly beneficial for people with diabetes, who are more prone to infections. By enhancing the duration of antibiotic coverage, cefadroxil might improve healing outcomes and reduce complications in these patients.

Studies have shown that cefadroxil can effectively treat bone and joint infections, particularly those caused by certain bacteria. In a large study, cefadroxil successfully treated 91.8% of infections. This trial will compare two approaches: one group will receive extended oral antibiotic prophylaxis with cefadroxil, while another group will follow standard institutional perioperative protocols without extended antibiotics. Previous research has shown that taking antibiotics for a longer time can reduce infection rates in high-risk surgery patients. Although cefadroxil's effectiveness in this specific situation isn't fully proven, its success in similar infections makes it a promising option.²⁶⁷⁸⁹